Patient Engagement in PTSD Treatment (PEP)
Key facts
- Who runs it
- Herlev and Gentofte Hospital
- Where
- Denmark1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 427 people, planned
- Started
- 2 Jan 2025
- Expected to end
- 31 Aug 2028
- Type of study
- Interventional, 3 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Introductory PTSD module
- Shared Decision Making
- Treatment as Usual
- Standardised treatments
- Record updated
- 14 July 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 14 criteriaShow less
Who can take part
- Adults (18 years or older)
- PTSD pursuant to the ICD-10 research criteria
- Signed informed consent
- patients referred to "Main Level" treatment
- Adult (18 years or older)
- Refugees or persons who have been family reunified with a refugee
- PTSD pursuant to the ICD-10 research criteria
- Psychological trauma experienced outside Denmark in the anamnesis. Trauma is imprisonment or detention with torture (according to the United Nations' definition of torture) or acts of cruel, inhuman and degrading treatment or punishment. Trauma can also be organised violence, long-term political persecution and harassment, or war and civil war experiences
- Signed informed consent
Who cannot take part
- Severe psychotic disorder (defined as patients with an ICD-10 diagnosis F2x and F30.1-F31.9). Participants are excluded only if the psychotic experiences are assessed to be part of an independent psychotic disorder and not part of a severe PTSD and/or depression
- Dependence syndrome of drugs or alcohol: Active dependence and use (F1x.24-F1x.26); In- and exclusion criteria of the randomised controlled trial for Competencecenter of Transcultural Psychiatry:
- Severe psychotic disorder (defined as patients with an ICD-10 diagnosis F2x and F30.1-F31.9). Participants are excluded only if the psychotic experiences are assessed to be part of an independent psychotic disorder and not part of a severe PTSD and/or depression
- Dependence syndrome of drugs or alcohol: Active dependence and use (F1x.24-F1x.26)
Other criteria
- In- and exclusion criteria of the randomised controlled trial for Psychotherapeutic Unit
This trial is currently available in Denmark.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The goal of this clinical study is to improve the outcome of outpatient PTSD treatment at two clinics treating majority ethnic Danes and refugees with PTSD respectively. The study will consist of two similar randomized controlled trials.
Read full original descriptionShow less
The main questions the study aims to answer are:
* Does an added motivation enhancement module as a precursor for PTSD treatment reduce dropout and increase treatment outcome? * Does an added Shared Decision-Making session which facilitate individualized treatment yield a superior outcome compared to PTSD treatment and PTSD treatment supplemented by motivation enhancement?
Participants are recruited at two different clinics, Psychotherapeutic Unit (PU) and Competence Centre for Transcultural Psychiatry (CTP). At PU the participants are randomized to one of two arms, and at CTP to one of three arms. One arm is the control group where participants will receive treatment as usual (TAU), one arm is the first intervention group where the participants will receive an Introductory PTSD module consisting of four sessions focusing on enhancing motivation for PTSD treatment, before continuing in TAU. The last arm is the second intervention group, which will only take place at CTP. Here the patient will receive the Introductory PTSD module followed by a session of Shared Decision Making, where the participant together with the MD decides which of four standardized treatment courses they will receive.
The treatment for all patients will last between 8-13 months.
The 3 groups in the trial
- Treatment as usual (TAU)Existing treatment, for comparison
8-12 months of treatment Interventions: Behavioral: treamtent as usual (TAU)
Treatment: Treatment as Usual
- Introductory PTSD module + TAUTreatment being tested
9-13 months of treatment An intervention with an introductory PTSD module consistent of four sessions focusing on motivation followed by TAU
Treatment: Introductory PTSD module and Treatment as Usual
- Introductory PTSD module + one session of Shared Decision Making + individualised treatmentTreatment being tested
9-13 months of treatment Add-on introductory PTSD module and add-on patient-centred shared decision making session before continuing in the chosen standardised treatment.
Treatment: Introductory PTSD module, Shared Decision Making, and Standardised treatments
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Patient Engagement in PTSD Treatment (PEP) - Advancing PTSD Treatment Outcomes
- Record updated
- 14 July 2026